tradingkey.logo

Dermata Announces That Last Patient Completes Last Visit In Pivotal Xyngari Phase 3 Star-1 Clinical Trial For Acne

ReutersMar 4, 2025 2:16 PM

- Dermata Therapeutics Inc DRMA.O:

  • DERMATA ANNOUNCES THAT LAST PATIENT COMPLETES LAST VISIT IN PIVOTAL XYNGARI™ PHASE 3 STAR-1 CLINICAL TRIAL FOR ACNE

  • DERMATA THERAPEUTICS INC - TOPLINE DATA EXPECTED BY END OF MARCH 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI